Melanoma
News and reporting on melanoma.
Early ESMO Data Show Interferon Signature's Ability to Guide Neoadjuvant Melanoma Immunotherapy
In the Phase I DOMINI trial, patients received combinations of BMS' Opdivo, Yervoy, and 4SC's domatinostat based on their tumors' interferon gamma gene expression.
Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test
The gene expression profile assay is meant to aid dermatopathologists in characterizing difficult-to-diagnose melanocytic lesions.
IO Biotech Studying Cancer Vaccine With Merck's Keytruda in Advanced Melanoma Patients
The company will study the activity of IO102-IO103 with Merck's anti-PD-1 drug in advanced melanoma patients and look for biomarkers of response.
Instil Bio to Begin Phase II Trial of TIL Therapy for Advanced Melanoma
The firm expects data from the trial to support regulatory filings for its autologous tumor-infiltrating lymphocyte treatment in the US and EU.
Obsidian Therapeutics Raises $115M in Series B Financing to Advance Engineered TIL Therapy
The firm hopes to advance its lead product candidate cytoTIL15 into the clinic for metastatic melanoma, and anticipates submitting an IND in mid-2022.
Aug 19, 2021
Jul 2, 2021
Feb 11, 2021
Jan 19, 2021
OncoHost Raises $8 Million in Series B Funding Round
Dec 23, 2020